CD4 and type 1 diabetes mellitus: To assess precision in a larger group of patients, one analyst measured CD4+ T-cell responses to PI33-63 and tetanus toxoid from freshly isolated PBMCs of five patients diagnosed with T1D ≤ 3 months (Figure 8).